Search Results

You are looking at 101 - 110 of 173 items for :

  • Refine by Access: All x
Clear All
Full access

Guru Subramanian Guru Murthy, Aniko Szabo, Laura Michaelis, Karen-Sue Carlson, Lyndsey Runaas, Sameem Abedin, and Ehab Atallah

accuracy, and better reporting and capturing of new cases, in addition to host factors such as obesity, which has been associated with APL. 12 Hispanic patients constituted 21.5% of the study cohort and had a higher disease incidence, similar to earlier

Full access

Yu Tian, Elham Kharazmi, Hermann Brenner, Xing Xu, Kristina Sundquist, Jan Sundquist, and Mahdi Fallah

admission for obesity, alcoholism, and chronic obstructive pulmonary disease, a surrogate measure of heavy smoking in our adjustment models. The age-specific cumulative risks were calculated for each family history group based on the following equations

Full access

Presenters: Robert Pilarski, Jennifer M. Weiss, Susan M. Domchek, and Moderated by Tuya Pal

of individuals with variants in these genes. “We know that risk based on family history, known exposures, lifestyle, and issues such as smoking and obesity can all help determine a personalized plan for individuals who have mutations in these moderate

Full access

Margaret A. Tempero, Mokenge P. Malafa, Mahmoud Al-Hawary, Stephen W. Behrman, Al B. Benson III, Dana B. Cardin, E. Gabriela Chiorean, Vincent Chung, Brian Czito, Marco Del Chiaro, Mary Dillhoff, Timothy R. Donahue, Efrat Dotan, Cristina R. Ferrone, Christos Fountzilas, Jeffrey Hardacre, William G. Hawkins, Kelsey Klute, Andrew H. Ko, John W. Kunstman, Noelle LoConte, Andrew M. Lowy, Cassadie Moravek, Eric K. Nakakura, Amol K. Narang, Jorge Obando, Patricio M. Polanco, Sushanth Reddy, Marsha Reyngold, Courtney Scaife, Jeanne Shen, Charles Vollmer Jr., Robert A. Wolff, Brian M. Wolpin, Beth Lynn, and Giby V. George

cancer than white Americans. 2 , 3 The incidence of pancreatic cancer in the United States increased from 1999 to 2008, possibly because of the increasing prevalence of obesity, an aging population, and other unknown factors. 3 – 5 Mortality rates have

Full access

Dawn Provenzale, Samir Gupta, Dennis J. Ahnen, Travis Bray, Jamie A. Cannon, Gregory Cooper, Donald S. David, Dayna S. Early, Deborah Erwin, James M. Ford, Francis M. Giardiello, William Grady, Amy L. Halverson, Stanley R. Hamilton, Heather Hampel, Mohammad K. Ismail, Jason B. Klapman, David W. Larson, Audrey J. Lazenby, Patrick M. Lynch, Robert J. Mayer, Reid M. Ness, Scott E. Regenbogen, Niloy Jewel Samadder, Moshe Shike, Gideon Steinbach, David Weinberg, Mary Dwyer, and Susan Darlow

completed less than 2 years of the intervention. Subgroup analyses from this trial showed that the association between obesity and CRC in patients with Lynch syndrome may be attenuated by taking daily aspirin. 81 However, limitations of the CAPP2 trial

Full access

Michael B. Streiff, Paula L. Bockenstedt, Spero R. Cataland, Carolyn Chesney, Charles Eby, John Fanikos, Patrick F. Fogarty, Shuwei Gao, Julio Garcia-Aguilar, Samuel Z. Goldhaber, Hani Hassoun, Paul Hendrie, Bjorn Holmstrom, Kimberly A. Jones, Nicole Kuderer, Jason T. Lee, Michael M. Millenson, Anne T. Neff, Thomas L. Ortel, Judy L. Smith, Gary C. Yee, and Anaadriana Zakarija

, 14 , 21 and obesity was also identified as a risk factor. 21 - 24 Evidence also shows that prechemotherapy thrombocytosis, 24 - 26 leukocytosis, 24 and hemoglobin level less than 10 g/dL 24 , 25 are predictive of VTE in patients undergoing

Full access

Pancreatic Adenocarcinoma, Version 2.2012

Featured Updates to the NCCN Guidelines

Margaret A. Tempero, J. Pablo Arnoletti, Stephen W. Behrman, Edgar Ben-Josef, Al B. Benson III, Ephraim S. Casper, Steven J. Cohen, Brian Czito, Joshua D. I. Ellenhorn, William G. Hawkins, Joseph Herman, John P. Hoffman, Andrew Ko, Srinadh Komanduri, Albert Koong, Wen Wee Ma, Mokenge P. Malafa, Nipun B. Merchant, Sean J. Mulvihill, Peter Muscarella II, Eric K. Nakakura, Jorge Obando, Martha B. Pitman, Aaron R. Sasson, Anitra Tally, Sarah P. Thayer, Samuel Whiting, Robert A. Wolff, Brian M. Wolpin, Deborah A. Freedman-Cass, and Dorothy A. Shead

: 277 – 300 . 3 Arnold LD Patel AV Yan Y . Are racial disparities in pancreatic cancer explained by smoking and overweight/obesity? Cancer Epidemiol Biomarkers Prev 2009 ; 18 : 2397 – 2405 . 4 StatBite . U.S. pancreatic cancer

Full access

Linda A. Jacobs and David J. Vaughn

obesity. 30 It is associated with cardiovascular morbidity and mortality, and has been described as a late complication among TC survivors. 31 , 32 In a study of 589 survivors who had unilateral orchiectomy, the prevalence of metabolic syndrome and

Full access

Renee W. Pinsky and Mark A. Helvie

and glandular tissue. In the setting of obesity, absolute measurement of density may be more significant. The heritability of breast density has been examined in several classic twin studies. Both Boyd et al. 29 and Ursin et al. 13 showed that

Full access

Linda S. Overholser and Carlin Callaway

, dyslipidemia, obesity, diabetes mellitus, unhealthy dietary habits, and smoking, contribute not only to CVD but also to cancer, and can also impact the course of cancer survivorship. These risk factors are also targets of preventive health counseling, screening